Results 41 to 50 of about 142,505 (235)

Thirty-month results after the treatment of post-LASIK ectasia with allogenic lenticule addition and corneal cross-linking: a case report

open access: yesBMC Ophthalmology, 2018
Background To report a first case of lenticule addition and corneal cross-linking for post-LASIK ectasia with associated corneal thinning. Case presentation Lenticule addition followed by corneal cross-linking was performed on the left eye of a patient ...
Meiyan Li   +6 more
doaj   +1 more source

Myopia

open access: yesThe Lancet, 2012
Myopia has emerged as a major health issue in east Asia, because of its increasingly high prevalence in the past few decades (now 80-90% in school-leavers), and because of the sight-threatening pathologies associated with high myopia, which now affects 10-20% of those completing secondary schooling in this part of the world.
Morgan, Ian   +2 more
openaire   +2 more sources

Ocular Refraction at Birth and Its Development During the First Year of Life in a Large Cohort of Babies in a Single Center in Northern Italy [PDF]

open access: yes, 2020
The purpose of this study was to investigate refraction at birth and during the first year of life in a large cohort of babies born in a single center in Northern Italy.
Bartollino S.   +7 more
core   +1 more source

Fifteen years follow-up of photorefractive keratectomy up to 10 D of myopia: outcomes and analysis of the refractive regression [PDF]

open access: yes, 2015
PURPOSE: To evaluate outcomes of photorefractive keratectomy up to -10.00 D of myopia and -4.50 of astigmatism and to develop a predictive model for the refractive changes in the long term.
ABBOUDA, ALESSANDRO   +3 more
core   +1 more source

Add-On Effect of 0.01% Atropine in Orthokeratology Wearers for Myopia Control in Children: A 2-Year Retrospective Study

open access: yesOphthalmology and Therapy, 2023
Introduction Orthokeratology (OK) and low-concentration atropine are recommended approaches for controlling myopia. However, children with younger age and lower myopia are more likely to experience rapid axial progression during OK or atropine ...
Linlin Du   +8 more
doaj   +1 more source

Human PrimPol mutation associated with high myopia has a DNA replication defect [PDF]

open access: yes, 2014
PrimPol is a primase-polymerase found in humans, and other eukaryotes, involved in bypassing lesions encountered during DNA replication. PrimPol employs both translesion synthesis and repriming mechanisms to facilitate lesion bypass by the replisome ...
Aguilera   +27 more
core   +1 more source

Ocular manifestations in Gorlin-Goltz syndrome [PDF]

open access: yes, 2019
Background: Gorlin-Goltz syndrome, also known as nevoid basal cell carcinoma syndrome, is a rare genetic disorder that is transmitted in an autosomal dominant manner with complete penetrance and variable expressivity.
Franzone, F.   +8 more
core   +1 more source

Peripapillary Vascular Reactivity in Primary Open-Angle Glaucoma With High Myopia by Using Optical Coherence Tomography Angiography

open access: yesFrontiers in Medicine, 2022
PurposeTo evaluate peripapillary vascular reactivity in primary open-angle glaucoma (POAG) with and without high myopia (HM) by using optical coherence tomography angiography (OCTA).MethodsThis prospective study enrolled 48 eyes with POAG, including 16 ...
Xintong Fan   +27 more
doaj   +1 more source

Ocular hypertension in myopia: analysis of contrast sensitivity [PDF]

open access: yes, 2018
Purpose: we evaluated the evolution of contrast sensitivity reduction in patients affected by ocular hypertension and glaucoma, with low to moderate myopia.
Arrico, L   +4 more
core   +1 more source

Effects of atropine 0.01% on refractive errors in children with myopia

open access: yesHeliyon, 2023
Background: Little is known about changes in astigmatism during atropine treatment. We aimed to explore the effects of atropine 0.01% eye drops on both spherical and cylindrical refractive errors in myopic children. Methods: Children aged 6–14 years with
Xingxue Zhu   +5 more
doaj  

Home - About - Disclaimer - Privacy